| Physician beliefs and patient preferences: a new look at regional variation in health care spending D Cutler, JS Skinner, AD Stern, D Wennberg American Economic Journal: Economic Policy 11 (1), 192-221, 2019 | 413 | 2019 |
| Will the stork return to Europe and Japan? Understanding fertility within developed nations J Feyrer, B Sacerdote, AD Stern Journal of Economic Perspectives 22 (3), 3-22, 2008 | 298 | 2008 |
| Adaptive platform trials: definition, design, conduct and reporting considerations Nature Reviews Drug Discovery 18 (10), 797-807, 2019 | 238 | 2019 |
| Germany’s digital health reforms in the COVID-19 era: lessons and opportunities for other countries S Gerke, AD Stern, T Minssen NPJ digital medicine 3 (1), 94, 2020 | 136 | 2020 |
| Innovation under regulatory uncertainty: Evidence from medical technology AD Stern Journal of public economics 145, 181-200, 2017 | 132 | 2017 |
| Evaluating the impact of the Baby-Friendly Hospital Initiative on breast-feeding rates: a multi-state analysis SS Hawkins, AD Stern, CF Baum, MW Gillman Public health nutrition 18 (2), 189-197, 2015 | 121 | 2015 |
| Did the rust belt become shiny? A study of cities and counties that lost steel and auto jobs in the 1980s [with comments] J Feyrer, B Sacerdote, AD Stern, A Saiz, WC Strange Brookings-Wharton Papers on Urban Affairs, 41-102, 2007 | 116 | 2007 |
| Compliance with the Baby-Friendly Hospital Initiative and impact on breastfeeding rates SS Hawkins, AD Stern, CF Baum, MW Gillman Archives of Disease in Childhood-Fetal and Neonatal Edition 99 (2), F138-F143, 2014 | 83 | 2014 |
| Quantifying the use of connected digital products in clinical research C Marra, JL Chen, A Coravos, AD Stern NPJ digital medicine 3 (1), 50, 2020 | 79 | 2020 |
| Advancing digital health applications: priorities for innovation in real-world evidence generation AD Stern, J Brönneke, JF Debatin, J Hagen, H Matthies, S Patel, I Clay, ... The Lancet Digital Health 4 (3), e200-e206, 2022 | 71 | 2022 |
| The impact of the entry of biosimilars: evidence from Europe FM Scott Morton, AD Stern, S Stern Review of Industrial Organization 53, 173-210, 2018 | 69 | 2018 |
| Do state breastfeeding laws in the USA promote breast feeding? SS Hawkins, AD Stern, MW Gillman J Epidemiol Community Health 67 (3), 250-256, 2013 | 65 | 2013 |
| Health app policy: international comparison of nine countries’ approaches A Essén, AD Stern, CB Haase, J Car, F Greaves, D Paparova, S Vandeput, ... NPJ digital medicine 5 (1), 31, 2022 | 59 | 2022 |
| Limits on use of health economic assessments for rare diseases HI Hyry, AD Stern, TM Cox, JCP Roos QJM: An International Journal of Medicine 107 (3), 241-245, 2014 | 59 | 2014 |
| Remote patient monitoring—overdue or overused? K Mecklai, N Smith, A Stern, DB Kramer N Engl J Med, 2021 | 55 | 2021 |
| Challenges and opportunities in software-driven medical devices WJ Gordon, AD Stern Nature biomedical engineering 3 (7), 493-497, 2019 | 42 | 2019 |
| How economics can shape precision medicines AD Stern, BM Alexander, A Chandra Science 355 (6330), 1131-1133, 2017 | 40 | 2017 |
| Cybersecurity features of digital medical devices: an analysis of FDA product summaries AD Stern, WJ Gordon, AB Landman, DB Kramer BMJ open 9 (6), e025374, 2019 | 39 | 2019 |
| Lessons from the impact of price regulation on the pricing of anticancer drugs in Germany: study assesses the effects of female political representation on mortality among … VD Lauenroth, AS Kesselheim, A Sarpatwari, AD Stern Health Affairs 39 (7), 1185-1193, 2020 | 38 | 2020 |
| Regulatory considerations to keep pace with innovation in digital health products J Torous, AD Stern, FT Bourgeois NPJ Digital Medicine 5 (1), 121, 2022 | 33 | 2022 |
| The Orphan Drug Act at 35: observations and an outlook for the twenty-first century N Bagley, B Berger, A Chandra, C Garthwaite, AD Stern Innovation policy and the economy 19 (1), 97-137, 2019 | 29 | 2019 |
| Regulatory, legal, and market aspects of smart wearables for cardiac monitoring JB Brönneke, J Müller, K Mouratis, J Hagen, AD Stern Sensors 21 (14), 4937, 2021 | 27 | 2021 |
| Characterizing the drug development pipeline for precision medicines A Chandra, C Garthwaite, AD Stern National Bureau of Economic Research, 2017 | 27 | 2017 |
| The impact of price regulation on the availability of new drugs in Germany AD Stern, F Pietrulla, A Herr, AS Kesselheim, A Sarpatwari Health Affairs 38 (7), 1182-1187, 2019 | 26 | 2019 |
| Evidence from ClinicalTrials. gov on the growth of digital health technologies in neurology trials L Masanneck, P Gieseler, WJ Gordon, SG Meuth, AD Stern npj Digital Medicine 6 (1), 23, 2023 | 24 | 2023 |
| Artificial intelligence and clinical decision making: the new nature of medical uncertainty V Harish, F Morgado, AD Stern, S Das Academic Medicine 96 (1), 31-36, 2021 | 22 | 2021 |
| It’s time to reform the Orphan Drug Act N Bagley, A Chandra, C Garthwaite, AD Stern NEJM Catalyst 4 (6), 2018 | 22 | 2018 |
| Want to see the future of digital health tools? Look to Germany AD Stern, H Matthies, J Hagen, JB Brönneke, JF Debatin Harvard Business Review 2, 2020 | 21 | 2020 |
| Regulatory oversight, causal inference, and safe and effective health care machine learning AD Stern, WN Price Biostatistics 21 (2), 363-367, 2020 | 21 | 2020 |
| Biosimilars And Follow-On Products In The United States: Adoption, Prices, And Users: Study examines the early years of entry of biosimilar and related follow-on products … AD Stern, JL Chen, M Ouellet, MR Trusheim, Z El-Kilani, A Jessup, ... Health Affairs 40 (6), 989-999, 2021 | 20 | 2021 |
| Innovation incentives and biomarkers AD Stern, BM Alexander, A Chandra Clinical Pharmacology & Therapeutics 103 (1), 34-36, 2018 | 20 | 2018 |
| Trends in remote patient monitoring use in traditional Medicare M Tang, CH Nakamoto, AD Stern, A Mehrotra JAMA Internal Medicine 182 (9), 1005-1006, 2022 | 18 | 2022 |
| Use of connected digital products in clinical research following the COVID-19 pandemic: a comprehensive analysis of clinical trials C Marra, WJ Gordon, AD Stern BMJ open 11 (6), e047341, 2021 | 18 | 2021 |
| Association of the meaningful use electronic health record incentive program with health information technology venture capital funding S Lite, WJ Gordon, AD Stern JAMA network open 3 (3), e201402-e201402, 2020 | 18 | 2020 |
| Assessing the Food and drug administration’s risk-based framework for software precertification with top health apps in the United States: quality improvement study N Alon, AD Stern, J Torous JMIR mHealth and uHealth 8 (10), e20482, 2020 | 17 | 2020 |
| Rapid Growth Of Remote Patient Monitoring Is Driven By A Small Number Of Primary Care Providers: Study examines the growth of remote patient monitoring. M Tang, A Mehrotra, AD Stern Health Affairs 41 (9), 1248-1254, 2022 | 14 | 2022 |
| Economic implications of the Society for Assisted Reproductive Technology embryo transfer guidelines: healthcare dollars saved by reducing iatrogenic triplets MS Lee, BT Evans, AD Stern, MD Hornstein Fertility and sterility 106 (1), 189-195. e3, 2016 | 14 | 2016 |
| Which markets (don't) drive pharmaceutical innovation? evidence from US Medicaid expansions C Garthwaite, R Sachs, AD Stern National Bureau of Economic Research, 2021 | 13 | 2021 |
| We should treat algorithms like prescription drugs A Coravos, I Chen, A Gordhandas, AD Stern Quartz, Feb 19, 2019 | 13 | 2019 |
| Why apps for managing chronic disease haven’t been widely used, and how to fix it RS Huckman, AD Stern Harv. Bus. Rev, 2018 | 13 | 2018 |
| Association between regulatory submission characteristics and recalls of medical devices receiving 510 (k) clearance AO Everhart, S Sen, AD Stern, Y Zhu, P Karaca-Mandic JAMA 329 (2), 144-156, 2023 | 11 | 2023 |
| AI insurance: how liability insurance can drive the responsible adoption of artificial intelligence in health care AD Stern, A Goldfarb, T Minssen, WN Price II NEJM Catalyst Innovations in Care Delivery 3 (4), CAT. 21.0242, 2022 | 11 | 2022 |
| The market reacts quickly: changes in paclitaxel vascular device purchasing within the Ascension Healthcare System. PP Monteleone, S Banerjee, P Kothapalli, AD Stern, D Fehder, R Ginor, ... The Journal of Invasive Cardiology 32 (1), 18-24, 2019 | 10 | 2019 |
| Recalls, innovation, and competitor response: Evidence from medical device firms GP Ball, JT Macher, AD Stern Harvard Business School, 2019 | 10 | 2019 |
| How artificial intelligence is changing health care delivery SF Sanders, M Terwiesch, WJ Gordon, AD Stern NEJM Catalyst 5 (5), 2019 | 8 | 2019 |
| Digital health reimbursement strategies of 8 European countries and Israel: scoping review and policy mapping R van Kessel, D Srivastava, I Kyriopoulos, G Monti, D Novillo-Ortiz, ... JMIR mHealth and uHealth 11 (1), e49003, 2023 | 7 | 2023 |
| Review times and adverse events for cardiovascular devices AD Stern, DB Kramer, M Ouellet, AS Kesselheim Nature biomedical engineering 1 (1), 0013, 2017 | 7* | 2017 |
| Ushering in safe, effective, secure, and ethical medicine in the digital era WJ Gordon, AR Coravos, AD Stern NPJ Digital Medicine 4 (1), 56, 2021 | 6 | 2021 |
| Regulatory Incentives for Innovation: The FDA's Breakthrough Therapy Designation A Chandra, J Kao, KL Miller, AD Stern Review of Economics and Statistics, 1-46, 2024 | 5 | 2024 |
| DiGA VADEMECUM: How to Launch Digital Health Apps in the German Healthcare System JB Brönneke, JF Debatin, J Hagen, P Kircher, H Matthies, AD Stern MWV, 2021 | 5 | 2021 |
| The Past, Present, and (Near) Future of Gene Therapy and Gene Editing J Pian, A Chandra, AD Stern NEJM Catalyst Innovations in Care Delivery 1 (5), 2020 | 5 | 2020 |
| The central and unacknowledged role of the US Food and Drug Administration in the design and execution of medical device pivotal trials AV Kaplan, AD Stern JAMA cardiology 3 (1), 5-6, 2018 | 5 | 2018 |
| Dynamic HTA for digital health solutions: opportunities and challenges for patient-centered evaluation JB Brönneke, A Herr, S Reif, AD Stern International Journal of Technology Assessment in Health Care, 1-21, 2023 | 4 | 2023 |
| Adaptive Platform Trials: The Clinical Trial of the Future? AD Stern, S Mehta Harvard Business Publishing, 2018 | 4 | 2018 |
| Federated electronic health records for the European Health Data Space R Raab, A Küderle, A Zakreuskaya, AD Stern, J Klucken, G Kaissis, ... The Lancet Digital Health 5 (11), e840-e847, 2023 | 3 | 2023 |
| Food and Drug Administration guidance documents and new medical devices: the case of breast prostheses RE Weitzman, AD Stern, DB Kramer American Journal of Therapeutics 28 (1), e127-e130, 2021 | 3 | 2021 |
| Product recalls and new product development: own firm distractions and competitor firm opportunities GP Ball, JT Macher, AD Stern Harvard Business School Working Paper, 19-028, 2020 | 3 | 2020 |
| Pioneer (dis-) advantages in Markets for Technology M Fischer, J Henkel, AD Stern Harvard Business School Working Paper, 2020 | 3 | 2020 |
| Editors are gatekeepers of science, but individual editors don't matter much JL Krieger, KR Myers, AD Stern Harvard Business School Entrepreneurial Management, 2021 | 2 | 2021 |
| How to make remote monitoring tech part of everyday health care S Sanders, A Stern, W Gordon | 2 | 2020 |
| Managing the Use and Dissemination of Information about Biomarkers: The Importance of Incentive Structures AD Stern The Journal of Law, Medicine & Ethics 47 (3), 396-397, 2019 | 2 | 2019 |
| Who Drives Digital Innovation?: Evidence from the US Medical Device Industry C Foroughi, AD Stern Harvard Business School, 2019 | 2 | 2019 |
| Digital Innovation with High Costs of Entry: Evidence from Software-Driven Medical Devices C Foroughi, AD Stern Harvard Business School, 2018 | 2 | 2018 |
| Negative shocks and innovation: Evidence from medical device recalls GP Ball, JT Macher, AD Stern Harvard Business School, 2018 | 2 | 2018 |
| Twine Health RS Huckman, AD Stern, MG Preble Harvard Business School Publishing, 2015 | 2 | 2015 |
| Effects of Remote Patient Monitoring Use on Care Outcomes Among Medicare Patients With Hypertension: An Observational Study M Tang, CH Nakamoto, AD Stern, JR Zubizarreta, FO Marcondes, ... Annals of Internal Medicine 176 (11), 1465-1475, 2023 | 1 | 2023 |
| Building the business case for an inclusive approach to digital health measurement with a web app (market opportunity calculator): instrument development study M Tang, Y Sharma, JC Goldsack, AD Stern JMIR Formative Research 7, e45713, 2023 | 1 | 2023 |
| How Important is Editorial Gatekeeping? Evidence from Top Biomedical Journals JL Krieger, KR Myers, AD Stern Review of Economics and Statistics, 1-33, 2023 | 1 | 2023 |
| The Regulation of Medical AI: Policy Approaches, Data, and Innovation Incentives AD Stern National Bureau of Economic Research, 2022 | 1 | 2022 |
| Overcoming Legal Liability Obstacles to AI Adoption AD Stern NEJM Catalyst Innovations in Care Delivery 3 (3), 2022 | 1 | 2022 |
| Will mRna Technology Companies Spawn Innovation Ecosystems? C Grimpe, T Minssen, WN Price II, AD Stern Harvard Business Review Digital Articles, 2022 | 1 | 2022 |
| On The Brink Of A Digital Health Care Transformation: What Germany Can Learn From The United States Y Goldwasser, WJ Gordon, JB Brönneke, AD Stern Health Affairs Forefront, 2021 | 1 | 2021 |
| Method and system for identifying a network-connected sensor device based on electrical fingerprint Y Poleg, A Stern, R Forte, I Sasson US Patent App. 15/220,442, 2017 | 1 | 2017 |
| Essays in the Economics of Health Care and the Regulation of Medical Technology AD Stern Harvard University, 2014 | 1 | 2014 |
| Tracing Digital Therapeutics Research Across Medical Specialties: Evidence from ClinicalTrails. gov L Masanneck, AD Stern Clinical Pharmacology & Therapeutics, 2024 | | 2024 |
| Differences in Care Team Response to Patient Portal Messages by Patient Race and Ethnicity M Tang, RG Mishuris, L Payvandi, AD Stern JAMA Network Open 7 (3), e242618-e242618, 2024 | | 2024 |
| Beyond the 510 (k): The regulation of novel moderate-risk medical devices, intellectual property considerations, and innovation incentives in the FDA’s De Novo pathway M Aboy, C Crespo, A Stern npj Digital Medicine 7 (1), 29, 2024 | | 2024 |
| Tepid Uptake of Digital Health Technologies in Clinical Trials by Pharmaceutical and Medical Device Firms C Marra, AD Stern Clinical Pharmacology & Therapeutics, 2024 | | 2024 |
| DYNAMIC HTA FOR DIGITAL HEALTH SOLUTIONS: OPPORTUNITIES AND CHALLENGES FOR PATIENT-CENTERED EVALUATION A Herr, S Reif, AD Stern Health Care, 2023 | | 2023 |
| Association between Remote Patient Monitoring Use and Care Outcomes Among Medicare Patients with Hypertension M Tang, C Nakamoto, A Stern, F Marcondes, A Mehrotra 2023 Annual Research Meeting, 2023 | | 2023 |
| Growing Use of Remote Patient Monitoring: A Step in the Right Direction or Too Much Too Soon? LA Polgreen, M Tang, AD Stern, A Mehrotra ASHEcon 2023 Conference, 2023 | | 2023 |
| Regulatory Submission Characteristics and Recalls of Medical Devices Receiving 510 (k) Clearance—Reply AO Everhart, Y Zhu, AD Stern JAMA 329 (18), 1609-1610, 2023 | | 2023 |
| Geography and a changing technology landscape: analysing coverage of German multiple sclerosis care networks and digital health technology adoption in multiple sclerosis trials L Masanneck, S Raeuber, P Gieseler, T Ruck, AD Stern, SG Meuth, ... MULTIPLE SCLEROSIS JOURNAL 28 (3_ SUPPL), 492-493, 2022 | | 2022 |
| Ein Booster für die Pharmabranche C Grimpe, T Minssen, WN Price II, AD Stern Harvard Business Manager, 10-11, 2022 | | 2022 |
| Predicate Characteristics and Recalls of 510 (k) Medical Devices A Everhart, S Sen, A Stern, Y Zhu, P Karaca-Mandic 2022 Annual Research Meeting, 2022 | | 2022 |
| Growing Use of Remote Patient Monitoring in the United States: A Step in the Right Direction or Too Much Too Soon? M Tang, A Mehrotra, A Stern 2022 Annual Research Meeting, 2022 | | 2022 |
| Barriers to AI Adoption in Care Delivery C Silcox, AD Stern, TH Lee NEJM Catalyst Innovations in Care Delivery 3 (3), 2022 | | 2022 |
| Revolutionize Remote Wireless Monitoring: with AI and High-Energy Lithium Batteries. A Stern, R Yaar Electronic Design 69 (5), 10-14, 2021 | | 2021 |
| Biosimilars And Follow-On Products/The Authors Reply B Feinberg, A Gajra, S Oskouei, AD Stern, MR Trusheim Health Affairs 40 (9), 1515-1516, 2021 | | 2021 |
| Biosimilars And Follow-On Products: The Authors Reply AD Stern, MR Trusheim Health Affairs 40 (9), 1516-1516, 2021 | | 2021 |
| Which Markets (Don’t) Drive Pharmaceutical Innovation? Evidence from US Medicaid Expansions J Feng, C Garthwaite, R Sachs, AD Stern 9th Annual Conference of the American Society of Health Economists, 2020 | | 2020 |
| Germany’s Digital Health Reforms in the COVID-19 Era: Lessons and Opportunities for Other Countries (preprint) S Gerke, AD Stern, T Minssen | | 2020 |
| The Value of (Biased) Information K Lofgren, L Hatfield, A Stern 41st Annual Meeting of the Society for Medical Decision Making, 2019 | | 2019 |
| Technology Acquisitions: Classic Strategic Management Questions in a New Light NN Brueller, G Chondrakis, P Desyllas Academy of Management Proceedings 2019 (1), 19161, 2019 | | 2019 |
| RECALLS, INNOVATION, AND COMPETITOR RESPONSE: EVIDENCE FROM MEDICAL DEVICE FIRMS JULY 2019 GP Ball, JT Macher, AD Stern | | 2019 |
| Author Correction: Adaptive platform trials: definition, design, conduct and reporting considerations (Nature Reviews Drug Discovery,(2019), 18, 10,(797-807), 10.1038/s41573 … BM Alexander, S Berry, K Viele, M Buxton, M Paoloni, R Lewis, ... Nature Reviews Drug Discovery 18 (10), 808-808, 2019 | | 2019 |
| Replication Studies, an Inherent Good? K Lofgren, A Stern 40th Annual Meeting of the Society for Medical Decision Making, 2018 | | 2018 |
| Method and system for scheduling transmit time slots for network-connected measurement units Y Poleg, A Stern US Patent 10,098,062, 2018 | | 2018 |
| Responding Strategically to Competitors' Failures: Evidence from Medical Device Recalls & New Product Submissions G Ball, JT Macher, AD Stern Harvard Business School Working Paper 19-028, Georgetown McDonough School of …, 2018 | | 2018 |
| ACA-Era Medicaid Expansion and Pharmaceutical Innovation B Shapiro, C Garthwaite, R Sachs, AD Stern 7th Annual Conference of the American Society of Health Economists, 2018 | | 2018 |
Amitabh ChandraProfessor, Harvard UniversityVerified email at harvard.edu
